BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Biosimilars
Artificial intelligence
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, March 28, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
April 12, 2016
View Archived Issues
Mymetics' HIV vaccine candidate shows promise in preclinical study
Read More
Ipsen describes novel melanocortin MC2 receptor antagonist for Cushing's disease
Read More
FDA grants fast track status for Carbavance
Read More
Immunogenicity and safety of MG-1109
Read More
Ariad initiates phase III trial of brigatinib in patients with ALK-positive NSCLC
Read More
Data reported from phase III study of surotomycin for CDAD
Read More
Altor BioScience and NCI partner to develop cancer immunotherapeutics
Read More
Encouraging results seen in phase II murepavadin study
Read More
Celgene exercises option to develop and commercialize Juno's CD19-directed drug candidates
Read More
Bayer Schering Pharma patents coagulation factor XIa and KLKB1 inhibitors
Read More
Araxes Pharma discloses RAS inhibitors
Read More
Gilead Sciences describes TBK1 and IKK-epsilon inhibitors
Read More
BTA-585 enters phase IIa trial for the treatment of RSV infections
Read More
Tetra Discovery Partners reports PDE4 inhibitors
Read More
Hydra Biosciences presents TRPA1 antagonists
Read More
GW Pharmaceuticals initiates phase III pivotal trial of Epidiolex in tuberous sclerosis complex
Read More
RedHill Biopharma starts phase II trial of Bekinda in patients with IBS-D
Read More
Enrollment open in phase I study of MIW-815 for advanced cancers
Read More
Hutchison MediPharma initiates first-in-human study of HMPL-689
Read More
Regeneron and Intellia sign CRISPR/Cas-based licensing and collaboration agreement
Read More
Cerecor awarded NIDA grant
Read More
Cardiac peptide proANP(31-67) beneficial in patients with congestive heart failure
Read More
Nordic Nanovector and PSI enter R&D agreement
Read More
FDA grants accelerated approval to Venclexta for relapsed/refractory CLL with 17p deletion
Read More
HalioDx and NanoString Technologies collaborate on gene expression assays in immuno-oncology
Read More
Molecular Stethoscope collaborates with academic and medical institutions on diagnostic development
Read More
Cancer metabolic imaging trial begins in U.K.
Read More